Serious adverse events · adults with hepatorenal syndrome
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes serious adverse events compared with conventional treatment (very low certainty).
1 finding from 1 review
Serious adverse events · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) showed no clear difference in serious adverse events compared with static cold storage (SCS) (moderate certainty).
1 finding from 1 review
Serious adverse events · people undergoing laparoscopic cholecystectomy.
It is very uncertain whether summary of findings table ‐ Intraperitoneal local anaesthetic changes serious adverse events compared with control (very low certainty).
1 finding from 1 review
Serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Serious adverse events · people with resectable cholangiocarcinoma
It is very uncertain whether adjuvant chemotherapy changes serious adverse events compared with no chemotherapy (very low certainty).
1 finding from 1 review
Serious adverse events · people with resectable cholangiocarcinoma
1 finding from 1 review
Serious adverse events · people with hepatocellular carcinoma
1 finding from 1 review
Serious adverse events · people with hepatocellular carcinoma
It is very uncertain whether radioembolisation changes serious adverse events compared with chemoembolisation (very low certainty).
1 finding from 1 review
Serious adverse events · people with hepatocellular carcinoma
1 finding from 1 review
Serious adverse events · adult patients with non‐paracetamol (acetaminophen)‐related acute liver failure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children with non‐paracetamol (acetaminophen)‐related acute liver failure
N‐acetylcysteine showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
1 finding from 1 review
Serious adverse events · cirrhotic participants with large ascites treated by paracentesis
It is very uncertain whether other plasma expanders changes serious adverse events compared with albumin (very low certainty).
1 finding from 1 review
Serious adverse events · patients with covert or overt hepatic encephalopathy
1 finding from 1 review
Serious adverse events · primary hepatocellular carcinoma
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Serious adverse events · adults with cirrhosis and hepatic encephalopathy
1 finding from 1 review
Serious adverse events · adults with oesophageal varices
Band ligation probably leads to lower serious adverse events compared with no intervention (moderate certainty).
1 finding from 1 review
Serious adverse events · adults with cirrhosis and gastroesophageal varices
Carvedilol showed no clear difference in serious adverse events compared with traditional, non‐selective beta‐blockers (low certainty).
1 finding from 1 review
Serious adverse events · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes serious adverse events compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Serious adverse events · people with advanced biliary tract carcinomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found